Samsara BioCapital as of March 31, 2025
Portfolio Holdings for Samsara BioCapital
Samsara BioCapital holds 37 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Scholar Rock Hldg Corp (SRRK) | 32.2 | $181M | 5.6M | 32.15 | |
| Kalaris Therapeutics (KLRS) | 16.4 | $92M | 11M | 8.03 | |
| Mineralys Therapeutics (MLYS) | 16.1 | $90M | 5.7M | 15.88 | |
| Neurogene (NGNE) | 3.6 | $20M | 1.7M | 11.71 | |
| Alumis (ALMS) | 3.6 | $20M | 3.3M | 6.14 | |
| Palvella Therapeutics Inc Ne (PVLA) | 3.4 | $19M | 680k | 27.99 | |
| Septerna (SEPN) | 3.3 | $18M | 3.1M | 5.79 | |
| Cargo Therapeutics (CRGX) | 3.2 | $18M | 4.4M | 4.07 | |
| Lenz Therapeutics (LENZ) | 2.4 | $14M | 526k | 25.71 | |
| Upstream Bio (UPB) | 2.3 | $13M | 2.1M | 6.12 | |
| Arcellx Common Stock (ACLX) | 1.6 | $8.9M | 135k | 65.60 | |
| Zymeworks Del (ZYME) | 1.4 | $7.9M | 667k | 11.91 | |
| Avadel Pharmaceuticals Com Shs (AVDL) | 1.4 | $7.6M | 968k | 7.83 | |
| Rhythm Pharmaceuticals (RYTM) | 1.3 | $7.3M | 138k | 52.97 | |
| Nkarta (NKTX) | 1.2 | $6.9M | 3.8M | 1.84 | |
| Gossamer Bio (GOSS) | 1.2 | $6.7M | 6.1M | 1.10 | |
| Acelyrin | 1.1 | $6.2M | 2.5M | 2.47 | |
| Contineum Therapeutics Cl A (CTNM) | 0.7 | $4.1M | 589k | 6.98 | |
| Vtv Therapeutics Cl A New (VTVT) | 0.6 | $3.6M | 207k | 17.32 | |
| Onkure Therapeutics Com Cl A (OKUR) | 0.6 | $3.5M | 824k | 4.30 | |
| Surrozen Com New (SRZN) | 0.5 | $2.8M | 241k | 11.66 | |
| Abivax Sa Sponsored Ads (ABVX) | 0.5 | $2.7M | 425k | 6.25 | |
| Sutro Biopharma | 0.3 | $1.4M | 2.2M | 0.65 | |
| Inozyme Pharma (INZY) | 0.3 | $1.4M | 1.6M | 0.91 | |
| Artiva Biotherapeutics (ARTV) | 0.2 | $875k | 292k | 3.00 | |
| Tango Therapeutics (TNGX) | 0.2 | $863k | 630k | 1.37 | |
| Prime Medicine (PRME) | 0.1 | $806k | 405k | 1.99 | |
| Leap Therapeutics Com New (CYPH) | 0.1 | $745k | 2.4M | 0.31 | |
| Hillevax | 0.1 | $580k | 400k | 1.45 | |
| Terns Pharmaceuticals (TERN) | 0.1 | $559k | 202k | 2.76 | |
| Bolt Biotherapeutics | 0.1 | $420k | 1.0M | 0.40 | |
| Curis (CRIS) | 0.1 | $391k | 186k | 2.10 | |
| Lyra Therapeutics | 0.0 | $176k | 1.4M | 0.13 | |
| Kronos Bio | 0.0 | $65k | 78k | 0.82 | |
| Nuvation Bio *w Exp 02/10/202 (NUVB.WS) | 0.0 | $43k | 133k | 0.32 | |
| Allakos | 0.0 | $39k | 172k | 0.23 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $3.0k | 100k | 0.03 |
